A carregar...
Changing R&D models in research-based pharmaceutical companies
New drugs serving unmet medical needs are one of the key value drivers of research-based pharmaceutical companies. The efficiency of research and development (R&D), defined as the successful approval and launch of new medicines (output) in the rate of the monetary investments required for R&...
Na minha lista:
| Publicado no: | J Transl Med |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4847363/ https://ncbi.nlm.nih.gov/pubmed/27118048 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-016-0838-4 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|